Home
 /
Papers
 /
Microbiology
 /
Reverse transcribed ssDNA derepresses translation of a retron antiviral protein
Preprint
Open access
V1
Top 1% · Validated by QED

Reverse transcribed ssDNA derepresses translation of a retron antiviral protein

Karen Zhang, Matías Rojas-Montero, Darshini Poola +10 more
October 2025
 ·
bioRxiv
 ·
DOI 
10.1101/2025.10.22.683967
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Microbiology this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By showing that msDNA activates rather than suppresses toxin translation through a novel hybrid RNA, this work overturns the canonical antitoxin model of retron immunity and reveals an unexpected riboregulatory logic in bacterial defense.

QED claims analysis

Summary

Type VI retrons employ an inverted defense mechanism in which phage-encoded recombination systems trigger accumulation of reverse-transcribed msDNA that derepresses translation of a toxic effector encoded within a hybrid RNA transcript, contrasting with canonical retrons where msDNA serves as an antitoxin that neutralizes effector activity.

See full analysis
Main Claim 1 –

Type VI retrons defend against phages without detectable msDNA

Main Claim 2 –

Phage recombination systems trigger Type VI retron defense

Supporting evidence

  • Type VI triggering requires both Red Beta and Exo
  • Phage triggers drive accumulation of full-length Vpa2 msDNA
Main Claim 3 –

Type VI retrons encode toxin and template in hybrid RNA

Supporting evidence

  • SP is the toxin; C-terminal hydrophobic core required
  • RT, HTH, and hyRNA form an in vivo complex
Main Claim 4 –

Reverse transcription is required for Type VI retron defense

Supporting evidence

  • Constitutive low-level msDNA is repressed by HTH

Abstract

Retrons are bacterial immune systems that prevent the spread of phages by initiating a toxic response within infected hosts. All previously characterized retrons produce high levels of multicopy single-stranded DNA (msDNA) in the cell by reverse transcription, which acts as an antitoxin in the absence of phage infection. However, we describe here a non-canonical mechanism for Type VI retrons, which do not produce detectable msDNA in the absence of phage, yet still provide phage defense. Focusing primarily on Retron-Vpa2, a Type VI retron from Vibrio parahaemolyticus, we show broad defense against phages and identify triggers of the system within phage recombination systems. Within the Retron-Vpa2 operon, we find a highly enriched, structured transcript that we term a hybrid RNA (hyRNA), which contains both the retron’s reverse transcription template and a translationally repressed toxic effector coding sequence. We find that phage infection induces the accumulation of high levels of msDNA and that this msDNA is necessary for derepressing translation of the antiviral toxin. These findings present key biological and mechanistic insights into a distinct group of retrons while highlighting the diversity of systems that participate in bacterial immunity.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?